Preparation and Characterization of MKT-077 Nanoparticles for Treatment of Alzheimer’s Disease and Other Tauopathies

E-ISSN： 2211-7393|2|4|217-226

ISSN： 2211-7385

Source： Pharmaceutical Nanotechnology, Vol.2, Iss.4, 2014-12, pp. : 217-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preparation and Characterization of Methylene blue Nanoparticles for Alzheimer’s Disease and Other Tauopathies

Current Drug Delivery, Vol. 11, Iss. 4, 2014-06 ,pp. : 541-550

Bentham Science Publishers

Access to resources Recommend Favorite

Current strategies for the treatment of Alzheimer’s disease and other tauopathies

By Dickey Chad A Petrucelli Leonard

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 665-676

Informa Healthcare

Access to resources Recommend Favorite

Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model

By Yusuf Mohammad Khan Maria Khan Riaz A. Ahmed Bahar

Journal of Drug Targeting, Vol. 21, Iss. 3, 2013-04 ,pp. : 300-311

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Neurofibrillary Degeneration: A Promising Approach to Alzheimer's Disease and Other Tauopathies

Current Drug Targets, Vol. 5, Iss. 6, 2004-08 ,pp. : 495-502

Bentham Science Publishers

Access to resources Recommend Favorite

Flavonoids in the Treatment of Alzheimer’s and Other Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 25, Iss. 27, 2018-08 ,pp. : 3228-3246

Bentham Science Publishers

Access to resources Recommend Favorite